TCT CONNECT-197 Outcomes of Percutaneous and Surgical Pulmonary Valve Implantation

Percutaneous pulmonary valve implantation

INTRODUCTION Percutaneous pulmonary valve implantation (PPVI) is one of the most exciting recent developments in the treatment of structural heart disease and has evolved as an attractive alternative to surgery in patients with dysfunctional right ventricle-pulmonary artery conduits. Although surgical pulmonary valve replacement is associated with low morbidity and mortality rates, there are ma...

Percutaneous Pulmonary Valve Implantation

Pulmonary regurgitation (PR) is a frequent sequelae after repair of tetralogy of Fallot, pulmonary atresia, truncus arteriosus, Rastelli and Ross operation. Due to patient growth and conduit degeneration, these conduits have to be changed frequently due to regurgitation or stenosis. However, morbidity is significant in these repeated operations. To prolong conduit longevity, bare-metal stenting...

Cost-analysis of percutaneous pulmonary valve implantation compared to surgical pulmonary valve replacement.

OBJECTIVES To perform cost evaluation and economic modeling of percutaneous pulmonary valve implantation (PPVI) compared to surgical revision. BACKGROUND While, PPVI appears to be a viable alternative to surgical conduit revision in select patients with right ventricular outflow tract anomalies, its overall economic burden has yet to be determined. METHODS AND RESULTS We examined the first ...

Percutaneous pulmonary valve implantation: is earlier valve implantation better?

Percutaneous implantation of a pulmonary valve.